For research and education only · Not reviewed by a medical professional · Disclaimer · Contains affiliate links

← PepsRadar home

CJC no DAC + ipamorelin blend

PRODUCT KNOWLEDGE · BioLongevity Labs

An equal-mass blend labeled CJC-1295 no DAC and ipamorelin; the no-DAC qualifier is essential.

Listing checked October 4, 2026 · Original AI-assisted notes · Not reviewed by a medical professional

DECLARED COMPOSITION

10 mg total
2 ingredients
  • CJC-1295 no DAC5 mg
  • Ipamorelin5 mg
Seller-declared ingredient masses. Bar widths show mass proportions, not potency, molecular structure, or an administration schedule.

What the supplier lists

Seller describes a lyophilized vial. The composition below is attributed to this listing; it is not an independent measurement.

Declared composition · BioLongevity Labs · October 4, 2026
Listed ingredientDeclared amountIdentity & research context
CJC-1295 no DAC5 mg

Related identity context only: our CJC-1295 profile includes DAC-containing study material, not this no-DAC formulation.

Modified GRF 1-29 research context →
CJC-1295 research context →
Ipamorelin5 mg

Named ingredient; individual research is not a trial of this blend.

Ipamorelin research context →

Composition source: Supplier composition and product description ↗ (affiliate link). A shared blend name can refer to different ingredients, ratios, or identities at another supplier.

Identity check

The title specifies no DAC, while the description also discusses long-acting albumin-binding CJC-1295. Preserve the no-DAC distinction rather than transferring the DAC trial's duration or findings to this listing.

Based on Supplier composition and product description ↗ (affiliate link); batch composition has not been independently verified.

Ingredient research and blend evidence

These are selected studies of individual ingredients or related identities. They did not validate the seller's finished blend. Open the linked profile for the population, design, results, and limitations.

INGREDIENT / RELATED IDENTITY

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. · 2005

Related conjugate · Animal and cell study · 2005

What did this publication test, and what did it find?

Read profile evidence → · Original publication ↗
INGREDIENT / RELATED IDENTITY

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

Human pharmacology trials · 2006

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

Read profile evidence → · Original publication ↗

Questions an exact-formulation study would need to answer

Different ingredients or plausible mechanisms do not establish synergy. A research-use designation is not a finding of clinical safety or efficacy.

Supplier listing and documentation

Supplier
BioLongevity Labs
Listed starting price
$99.97
Snapshot availability
Listed in stock
Price check
2026-10-04

Price and availability are dated listing snapshots. Shipping, taxes, options, and later changes are excluded.

Supplier composition and product description ↗ (affiliate link)

Direct link · No affiliate commission active. Listing inclusion does not verify the product or endorse the supplier.

Explore supplier documents →

A product description or general purity claim does not verify every ingredient or ratio in a purchased lot. Match the lot identifier, analytes, methods, and quantitative results to the specific material; a certificate does not establish a clinical outcome.

Continue researching

Browse product knowledge → · Browse supplier catalog →

Educational product reference. No dosing, mixing, or administration instructions are provided. Medical and full-formulation evidence review remain pending.